XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Japan’s 3 Largest Banks Report Stablecoin Payment
Japan’s three largest banks have reported completing what they describe as the country’s first international crypto stablecoin payment, marking a rare instance...
Visa launches stablecoin payments via Visa Direct
Visa is adding stablecoin payment capability to Visa Direct, its real-time push-payments network, targeting near-instant global payouts for businesses and their...
Binance bStocks Reportedly Tops $1B AUM Four Months After Launch
Binance’s bStocks tokenized-stock offering has reportedly crossed $1 billion in assets under management, according to unconfirmed reports circulating within the...
Cross River Bank Partners With Ripple to Expand RLUSD Use
Cross River Bank has announced a partnership with Ripple aimed at expanding banking-grade use cases for RLUSD, Ripple’s US dollar-backed stablecoin. The deal ma...
Ledger Unveils $849 Android-Based Atom Signer
Ledger has unveiled Atom, a new hardware signing device built on Android and priced at $849, marking the company’s latest push into the premium end of the crypt...
Binance Requires Full USDC Reserves for Stock Put Sellers
A stock put option gives the buyer the right to sell shares at a fixed strike price. The seller, or writer, takes the other side, accepting a possible obligatio...
